Skip to main content
. 2018 Aug 24;8:12787. doi: 10.1038/s41598-018-31119-9

Table 3.

Liver cancer incidence and mortality 2012–2015*.

Participants (N = 17,966) Non-participants (N = 50,544) Participants vs. non- participants
No. of cases Rate per 100,000 person-years (95% CI) No. of cases Rate per 100,000 person-years (95% CI) Adjusted relative risk (95% CI)†† P value
Liver cancer incidence 57 79.4 104 54.6 1.21 (0.88, 1.68) 0.244
Sex
Male 52 134.2 91 109.5 1.21 (0.86, 1.70) 0.275
Female 5 13.1 13 12.3 1.13 (0.40, 3.20) 0.813
Age in 2012 (years)
35–49 17 57.2 30 25.0 1.46 (0.80, 2.66) 0.215
50–64 30 86.5 74 92.0 1.13 (0.77, 1.66) 0.530
Calendar year
2012 15 115.0 25 55.2 1.95 (1.02, 3.71) 0.042
2013 11 55.6 22 45.1 1.03 (0.50, 2.14) 0.931
2014 16 73.1 24 49.8 1.36 (0.72, 2.57) 0.346
2015 15 80.9 33 61.6 0.89 (0.48, 1.65) 0.721
All-cause mortality 274 376.2 699 369.7 0.91 (0.79, 1.04) 0.167
Liver cancer mortality 33 44.9 69 36.2 1.04 (0.68, 1.58) 0.856
Sex
Male 33 84.7 59 70.9 1.18 (0.77, 1.80) 0.456
Female 0 0.0 10 9.4 0 N/A
Age in 2012 (years)
35–49 11 37.0 17 14.1 1.66 (0.77, 3.56) 0.193
50–64 22 63.3 52 64.6 0.88 (0.53, 1.45) 0.611

*The median follow-up time for incidence was 4.0 years (interquartile range, 3.8 to 4.0), and for mortality was 4.0 years (interquartile range, 3.8 to 4.0).

Incidence rate per 100 000 person-years, standardized to age distribution of person-years experienced by all residents using 5-year age categories.

††Adjusted for sex and age. For analyses stratified by sex, models were only adjusted for age. For analyses stratified by age, models were only adjusted for sex.